[go: up one dir, main page]

PE20050465A1 - Compuestos derivados de quinuclidina como antagonistas del receptor muscarinico m3 - Google Patents

Compuestos derivados de quinuclidina como antagonistas del receptor muscarinico m3

Info

Publication number
PE20050465A1
PE20050465A1 PE2004000435A PE2004000435A PE20050465A1 PE 20050465 A1 PE20050465 A1 PE 20050465A1 PE 2004000435 A PE2004000435 A PE 2004000435A PE 2004000435 A PE2004000435 A PE 2004000435A PE 20050465 A1 PE20050465 A1 PE 20050465A1
Authority
PE
Peru
Prior art keywords
azonia
acetoxy
octane
bicycle
diphenyl
Prior art date
Application number
PE2004000435A
Other languages
English (en)
Inventor
Stephen Paul Collingwood
Brian Cox
Urs Baettig
Gurdip Bhalay
Nicholas James Devereux
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20050465(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0324887A external-priority patent/GB0324887D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20050465A1 publication Critical patent/PE20050465A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE QUINUCLIDINA DE FORMULA (I), DONDE R1 Y R3 SON INDEPENDIENTEMENTE, CARBOCICLICO (C3-C15), O UN HETEROCICLO DE 4 A 12 MIEMBROS Y POR LO MENOS CON UN ANILLO HETEROGENEO SELECCIONADO DE N, O Y S; O -CR1R2R3 JUNTOS FORMAN UN GRUPO DE FORMULA (i) DONDE R ES -O-, -S-, -CH2-, -CH=CH-, -CH2-CH2-, AMINO O -N(CH3)-; R2 ES H, HALOGENO, -OH, ALCOXI O ALQUILO(C1-C8); R4 ES ALQUILO(C1-C8) SUSTITUIDO POR -NR5, -NR5-CO-R6, -NR5-CO-NH-R7-, ENTRE OTROS, O ES ALQUINILO(C3-C10), OPCIONALMENTE SUSTITUIDO. SON COMPUESTOS PREFERIDOS: TRIFLUOROACETATO DE (R)-3-(2-HIDROXI-2,2-DIFENIL-ACETOXI)-1-[3-(3-FENIL-UREIDO)-PROPIL]1-AZONIA-BICICLO[2,2,2]-OCTANO, (R)-3-(2-HIDROXI-2,2-DIFENIL-ACETOXI)-1-FENILCARBAMOILMETIL-1-AZONIA-BICICLO[2,2,2]-OCTANO, BROMURO DE (R)-3-(2-FLUORO-2,2-DIFENIL-ACETOXI)-1-FENOXICARBONILMETIL-1-AZONIA-BICICLO[2,2,2]-OCTANO, ENTRE OTROS. TAMBIEN SE REFIERE A PROCEDIMIENTO DE OBTENCION. ESTOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR MUSCARINICO M3 Y PUEDEN PRESENTARSE EN COMBINACION CON UN ANTIINFLAMATORIO, BRONCODILATADOR, ANTIHISTAMINICO, ENTRE OTROS, Y SON UTILES PARA ELTRATAMIENTO DE ENFERMEDADES INFLAMATORIAS U OBSTRUCTIVAS DE LAS VIAS RESPIRATORIAS
PE2004000435A 2003-05-02 2004-04-30 Compuestos derivados de quinuclidina como antagonistas del receptor muscarinico m3 PE20050465A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0310232 2003-05-02
GB0324887A GB0324887D0 (en) 2003-10-24 2003-10-24 Organic compounds

Publications (1)

Publication Number Publication Date
PE20050465A1 true PE20050465A1 (es) 2005-07-18

Family

ID=33420896

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000435A PE20050465A1 (es) 2003-05-02 2004-04-30 Compuestos derivados de quinuclidina como antagonistas del receptor muscarinico m3

Country Status (31)

Country Link
US (2) US20070060563A1 (es)
EP (1) EP1631569B1 (es)
JP (1) JP4416786B2 (es)
KR (1) KR100896544B1 (es)
AR (1) AR044134A1 (es)
AT (1) ATE440840T1 (es)
AU (1) AU2004234069B2 (es)
BR (1) BRPI0410238A (es)
CA (1) CA2523436C (es)
CL (1) CL2004000918A1 (es)
CO (1) CO5700782A2 (es)
CY (1) CY1109655T1 (es)
DE (1) DE602004022805D1 (es)
DK (1) DK1631569T3 (es)
EC (1) ECSP056134A (es)
ES (1) ES2331185T3 (es)
HR (1) HRP20050933A2 (es)
IL (1) IL171591A (es)
IS (1) IS2746B (es)
MA (1) MA27775A1 (es)
MX (1) MXPA05011739A (es)
MY (1) MY142652A (es)
NO (1) NO20055688L (es)
NZ (1) NZ542995A (es)
PE (1) PE20050465A1 (es)
PL (1) PL1631569T3 (es)
PT (1) PT1631569E (es)
RU (1) RU2363700C2 (es)
SI (1) SI1631569T1 (es)
TW (1) TWI340139B (es)
WO (1) WO2004096800A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
GB0410712D0 (en) 2004-05-13 2004-06-16 Novartis Ag Organic compounds
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP1894568A1 (en) * 2006-08-31 2008-03-05 Novartis AG Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
JP4604129B2 (ja) * 2006-12-19 2010-12-22 アストラゼネカ・アクチエボラーグ ムスカリン受容体アンタゴニストとしてのキヌクリジノール誘導体
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
KR101517574B1 (ko) * 2007-09-07 2015-05-07 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 무스카린 수용체 길항제로서 유용한 구아니딘을 함유하는 화합물
US8017617B2 (en) 2007-12-14 2011-09-13 Theravance, Inc. Amidine-containing compounds useful as muscarinic receptor antagonists
KR20100113557A (ko) 2008-01-11 2010-10-21 노파르티스 아게 키나제 억제제로서의 피리미딘
BRPI0912657A2 (pt) * 2008-05-13 2016-01-26 Astrazeneca Ab produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista beta2-adrenorreceptor
GB0808709D0 (en) * 2008-05-13 2008-06-18 Astrazeneca Ab New combination 295
EA017627B1 (ru) * 2008-05-13 2013-01-30 Астразенека Аб Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
WO2009153536A1 (en) * 2008-06-17 2009-12-23 Argenta Discovery Limited 1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists
GB0811100D0 (en) * 2008-06-17 2008-07-23 Astrazeneca Ab New combination
CN102947300B (zh) * 2010-06-22 2016-09-21 奇斯药制品公司 生物碱氨基酯衍生物及其药物组合物
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US9102671B2 (en) 2011-02-25 2015-08-11 Novartis Ag Compounds and compositions as TRK inhibitors
JP2011195593A (ja) * 2011-06-30 2011-10-06 Astrazeneca Ab ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
KR20140105746A (ko) * 2011-12-30 2014-09-02 키에시 파르마슈티시 엣스. 피. 에이. 항무스카린제로서 1-아자헤테로시클릴아세트산의 퀴누클리딘 에스터, 이들의 제조 방법 및 이들의 의약 조성물
US9687488B2 (en) 2012-05-03 2017-06-27 St. Louis College Of Pharmacy Compositions and methods for increasing neurotrophic peptides
TWI647227B (zh) * 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 ２－醯胺噻唑衍生物或其鹽
CZ306791B6 (cs) 2013-10-29 2017-07-12 Zentiva, K.S. Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
ES2897697T3 (es) 2015-07-03 2022-03-02 Novartis Ag Inhalador adaptado para leer información almacenada en un medio de almacenamiento de datos de un recipiente

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
DK534178A (da) * 1977-12-16 1979-06-17 Interx Research Corp Anticholinerge midler med sektrtionshaemmende virkning
IT1230881B (it) * 1989-06-20 1991-11-08 Angeli Inst Spa Derivati del r(-) 3-chinuclidinolo
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
WO2002004402A1 (en) * 2000-07-11 2002-01-17 Banyu Pharmaceutical Co., Ltd. Ester derivatives
DK1353919T3 (da) * 2000-12-28 2006-11-20 Almirall Prodesfarma Ag Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
UA76571C2 (en) * 2001-12-20 2006-08-15 Derivatives of 1-alkyl-1-azoniabicyclo [2.2.2.]octanecarbamate and use thereof as antagonists of muscarin receptor
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide

Also Published As

Publication number Publication date
CA2523436A1 (en) 2004-11-11
PL1631569T3 (pl) 2010-02-26
BRPI0410238A (pt) 2006-05-16
IS2746B (is) 2011-08-15
NO20055688D0 (no) 2005-12-01
RU2363700C2 (ru) 2009-08-10
NZ542995A (en) 2009-02-28
CO5700782A2 (es) 2006-11-30
AU2004234069B2 (en) 2008-02-21
ES2331185T3 (es) 2009-12-23
IS8158A (is) 2005-11-30
HK1087704A1 (en) 2006-10-20
KR20060015572A (ko) 2006-02-17
MY142652A (en) 2010-12-15
CL2004000918A1 (es) 2005-02-11
WO2004096800A3 (en) 2005-01-06
US20100041887A1 (en) 2010-02-18
KR100896544B1 (ko) 2009-05-07
MXPA05011739A (es) 2006-01-26
SI1631569T1 (sl) 2010-01-29
JP4416786B2 (ja) 2010-02-17
DE602004022805D1 (de) 2009-10-08
CY1109655T1 (el) 2014-08-13
DK1631569T3 (da) 2009-11-23
US8168654B2 (en) 2012-05-01
ECSP056134A (es) 2006-04-19
JP2006525267A (ja) 2006-11-09
NO20055688L (no) 2006-01-09
MA27775A1 (fr) 2006-02-01
EP1631569B1 (en) 2009-08-26
EP1631569A2 (en) 2006-03-08
WO2004096800A2 (en) 2004-11-11
AR044134A1 (es) 2005-08-24
PT1631569E (pt) 2009-11-26
AU2004234069A1 (en) 2004-11-11
CA2523436C (en) 2011-11-01
US20070060563A1 (en) 2007-03-15
HRP20050933A2 (en) 2006-12-31
ATE440840T1 (de) 2009-09-15
TW200505920A (en) 2005-02-16
TWI340139B (en) 2011-04-11
IL171591A (en) 2010-11-30
RU2005137360A (ru) 2006-07-27

Similar Documents

Publication Publication Date Title
PE20050465A1 (es) Compuestos derivados de quinuclidina como antagonistas del receptor muscarinico m3
EP0731802B1 (en) N-substituted azabicycloalkane derivatives as neuroleptics etc.
US5308854A (en) Inhibitors of HIV reverse transcriptase
JP5087171B2 (ja) ５−ヒドロキシトリプタミン−６リガンドとしての１−（アリールスルホニル）−４−（ピペラジン−１−イル）−１ｈ−ベンズイミダゾール類
US6316470B1 (en) Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
US8546402B2 (en) Chromone derivatives, a process for their preparation and their therapeutic applications
US20030008874A1 (en) 1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists
AR006545A1 (es) Compuestos sustitutos de las catecolaminas, utiles como antagonistas beta3, composiciones farmaceuticas que los contienen y compuestos intermediarios deaplicacion exclusiva en la preparacion de dichos compuestos
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
PE20040120A1 (es) Derivados de quinolina como antagonistas de npy
CL2003002050A1 (es) Compuestos derivados de 1-piperazin-1,2-dihidroindeno, su composicion farmaceutica y el uso de esta para tratar enfermedades del sistema nervioso central.
PE20060483A1 (es) Compuestos heterociclicos como antagonistas de nk1
PE75199A1 (es) Derivado de quinolina util como antagonista de neuroquinina
PE20060653A1 (es) Derivados triciclicos condensados como moduladores del receptor 5-ht1
AR052314A1 (es) Compuestos de tienopiridinona como agonistas del receptor 5-ht4
MX2007004199A (es) Derivados de indol sustituidos con 5-sulfonil-1-piperidinil como antagonistas del receptor 5-ht6 para el tratamiento de trastornos del cns.
PE20081574A1 (es) DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR DE LA V1a
BR0009582A (pt) Composto, composição farmacêutica, e, processopara o tratamento de uma condição de doençaselecionada de artrite reumatóide, doença dealzheimer, câncer, esquizofrenia, edema, rinitealérgica, inflamação, dor, hipermobilidadegastrointestinal , asma gástrica, refluxogastroesfageal, ansiedade, emese, doença dehuntington, psicoses incluindo depressão,hipertensão, enxaqueca e urticária
PE20051152A1 (es) Antagonistas del receptor de acetilcolina muscarinico m3
EP2616440A1 (en) Arylosulfonamides for the treatment of cns diseases
CN1136807A (zh) N-取代的氮杂二环庚烷衍生物、它们的制备及应用
US5908844A (en) N-substituted azabicycloalkane derivatives, their preparation and use
EA200501594A1 (ru) Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора
ATE263150T1 (de) Il-8 rezeptor antagonisten

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed